You Are Here: Home » Notizie dal mondo » Cellule Staminali » Hadasit sells stem cell co Cell Cure stake

Hadasit sells stem cell co Cell Cure stake

Hadasit sells stem cell co Cell Cure stake

Hadasit sold its 21% stake in Cell Cure, which develops stem cell implants for treatment of retinal degeneration, to BioTime for $12.75 million.

Leave a Comment

Current month ye@r day *

Scroll to top